Toronto, Canada (PRWEB) June 26, 2012
One of the greatest concerns for an individual suffering from deep vein thrombosis (DVT) is the threat of their illness developing into the debilitating Post Thrombotic Syndrome (PTS) also known as Post Phlebitic Syndrome(PPS). Statistics claim that up to 40% of those who suffer from Deep Vein Thrombosis may go on to develop PTS. Post Thrombotic Syndrome is responsible for considerable disability, reduced quality of life and increased health care costs (estimated at over $250 million USD). Traditional therapies for PTS are not only limited but often ineffective. The Venowave VW5 has made a stunning breakthrough offering new hope for patients suffering with PTS.
After years of being underserved, Post Thrombotic Syndrome sufferers finally have a life line. Saringer Life Science Technologies Inc. has developed the Venowave VW5- a lightweight, compact, battery operated compression pump designed to treat and alleviate the symptoms associated with poor circulation. The Venowave VW5, inspired by inventor and entrepreneur, John Saringer—working with Dr. Jack Hirsh, a professor of medicine at McMaster University, says the Venowave VW5 has a natural superiority over compression stockings, the traditional gold standard in PTS treatment. Clinical studies confirm that compression stockings have limited effectiveness. Other traditional treatments for PTS such as pneumatic pumps are considered large and impractical; PTS sufferers had formally given up hope- until now.
Founder of Saringer Life Science Technologies, John Saringer informs, “I recognized the need for a user-friendly device that pumps blood reducing swelling and is mobile and discreet so that patients could comfortably wear the device for hours while still maintaining an active lifestyle.”
The Venowave VW5 and its patented wave form motion technology is revolutionary in its field. The unique medical innovation is portable and completely cordless, lightweight and small in size allowing for high patient compliance and more significant results. The Venowave VW5 consists of a small peristaltic pump that is attached around the calf which mimics the body’s venous system relieving pressure & decreasing swelling in the lower leg. After a series of clinical trials, studies show that the product is clinically proven to reduce the symptoms of PTS by improving circulation. The quality of life for PTS patients significantly improved while using the Venowave.
Saringer Life Science Technologies Inc. is a privately-owned company that was founded by engineer/inventor, John Saringer. John works extensively with leading physicians/surgeons in the development of new and improved medical treatment devices in the fields of DVT prevention, vascular solutions, wound healing intervention and pain management. For more information, please visit http://www.venowave.com.